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Summary.-The long-term effects of Adriamycin (ADR), daunomycin (DMN) and
cis-dichlorodiammine platinum (II) (DDP) on the ability of murine renal tubular
epithelium and erythropoiesis to respond to an acute proliferative stress was investi-
gated. Folic acid (FA) and acute anaemia induced by bleeding were used as acute
proliferative stimuli for renal-tubule epithelium and erythropoiesis respectively.
The ability of these normal cell-renewal systems to mount a regenerative prolifera-
tive response was evaluated by radioisotopic, morphological and gravimetric tech-
niques 4 months after drug treatment. The results indicate that pretreatment with
these agents produce a long-lasting reduction in the ability of these cell-renewal
systems to mount regenerative proliferation. In the kidney, the ability to respond to
FA was most severely compromised by ADR and DDP, whereas in the erythropoietic
system all 3 agents induced a long-lasting proliferative defect.
THE DEVELOPMENT of new therapeutic
drugs, new techniques and machines in
radiotherapy, and new conceptual
approaches to sequential and combined-
modality therapy has led to significant
improvements in cancer treatment. These
advances, however, have not been made
without attendant toxicity to critical
normal tissues. Acute toxicity from chemo-
therapeutic drugs can be clinically docu-
mented with relative ease, but delayed
toxicity or the potential for late adverse
interactions with radiation are difficult to
predict, and often difficult to manage
(Tefft et al., 1976; Random et al., 1979).
Pulmonary fibrosis after bleomycin
(Nygaard et al., 1978), gastrointestinal
complications after Adriamycin (ADR)
and radiation (Mayer et al., 1976; Phillips
& Fu, 1976, Ransom et al., 1979) and
long-lasting renal injury after cis-dichloro-
diammine platinum (II) (DDP) (Ansair
et al., 1980; Bruno et al., 1980; Bobrow,
1972; Dentino et al., 1978; Freeman et al.,
1979) have been documented. These and
other delayed toxicities are most likely
manifestations of a reduced ability to
mount a regenerative response to a cyto-
toxic insult in normal cell-renewal systems.
In experimental animal models, long-
lasting proliferative defects induced by
chemotherapeutic drugs and radiation
have been studied in haemopoietic (Gong
et al., 1969; Botnick et al., 1978), lympho-
poietic (Botnick et al., 1978) and intestinal
(Schenken et al., 1979) cell-renewal sys-
tems. We have now extended our studies
on delayed proliferative defects in the
kidney after DDP (Braunschweiger et al.,
1980b) to include the delayed effects of
ADR and daunomycin (DMN) in both
the renal-tubule epithelium and haemo-
poietic cell-renewal systems.
METHODS AND MATERIALS
Mice and drug treatments-.Male BDF1
mice (Jax) used throughout these studies
were housed, 6-8/cage, in animal quarters
* To wlhom reprint requests should be addressed.
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with a 12h photoperiod. Mice were fed stan-
dard mouse chow (Purine, Evanston, IL,
U.S.A.) and water ad libitum. At 6-8 weeks of
age, mice were injected i.p. with freshly
prepared daunomycin (DMN, 1-3 mg/kg,
NCI, Bethesda, MD, U.S.A.), Adriamycin
(ADR, 10 mg/kg, Adria Labs, Columbus, OH,
U.S.A.) or cis-dichlorodiammine platinum II
(DDP, 8 mg/kg, NCI, Bethesda, MD, U.S.A.)
in 0.9% NaCl (0-1 ml/g animal weight) and
the response to a proliferative stress assessed
120 days later. Drug doses were chosen on
the basis of acute toxicity constraints in our
mice. The doses of ADR (- 15 mg/M2) and
DDP (- 40 mg/M2) are similar to what may
be used clinically, while the DMN dose
(' 6 mg/M2) is about one fifth that used
clinically.
Measurements ofproliferative reserve.-The
proliferative reserve of the renal-tubule
epithelium was assessed by evaluating 3H-
(methyl)-thymidine [3H]dT uptake after
folic-acid- (FA)-induced acute tubular nec-
rosis. In most studies FA was administered
in 0.9% NaCl as a suspension; however, in
the FA dose-response study some animals
received graded doses ofFA in 0-3M Na2 CO3.
At 120 days after drug treatment mice
were weighed and injected i.p. with 125 mg/
kg FA suspended in0.9% NaCl. After various
intervals, mice were injected i.p. with
[3H]dT, (1 ,uCi/g body wt, 15-17 Ci/mmol,
NEN, Boston, MA, U.S.A.) and killed 1 h
later. The right kidney was weighed and fixed
in Clarke's fixative for 24 h, rinsed in 2
changes of 80% ethanol for 24 h and solu-
bilized in 3 ml of tissue solubilizer (Soluene,
NEN, Boston, MA, U.S.A.). Aliquots were
then counted in a liquid-scintillation spectro-
meter with internal quench correction and
absolute activity analyser. The results were
expressed asd/min/kidney.
The left kidney was weighed and fixed in
buffered formalin, embedded in paraffin and
4,um sections prepared for autoradiography.
The sections, prestained with eosin, were
dipped in NTB-2 liquid photographic emul-
sion (Kodak, Rochester, NY, U.S.A.), air-
dried, and exposed at 4°C for 2-3 weeks. At
appropriate times, the autoradiograms were
developed (D-19, Kodak), fixed, washed,
counterstained withhaematoxylin, and cover-
slipped. Labelling indices (LI) were deter-
mined by counting at least 2000 cells in the
renal cortex, and expressed as a percentage
of the total population. Mean grain counts
were >50 grains/labelled cell and cells were
deemed labelled if >3 grains were observed
over the nucleus. Background grain count
was <1 grain/mean cell area. Glomerular,
medullary and interstitial cells were not
counted.
The proliferative response to anaemic
stress was evaluated as previously described
(Braunschweiger et al., 1980b). At 120 days
after drug treatment, pretreated and
untreated controls were bled 1/3 of their
calculated blood volume from the postorbital
venous plexus at each of2 sessions 24 h apart.
Before each bleeding, mice were injected i.p.
with a volume of warm 0.9% NaCl equal to
the predetermined blood volume to be
removed. Before killing, 48 h after induction
of anaemia, haematocrit determinations were
made on bled and non-bled groups. The
bleeding procedure routinely halved the
haematocrit. The mice were killed by cervical
dislocation and the spleens and femurs
removed. The spleens were weighed and
minced in bovine serum (GIBCO, Grand
Island, NY, U.S.A.). The suspension was
filtered through nylon gauze, and aliquots
were then applied to microscope slides with a
cytocentrifuge (Cytospin, Shandon Elliott,
Sewickley, PA, U.S.A.). Femoral marrow
cytocentrifuge preparations were similarly
prepared (Braunschweiger et al., 1980b). The
fraction of nucleated erythroid precursors
were determined by counting at least 500
cells in Wright-Giemsa-stained spleen and
marrow preparations.
In both the kidney and the erythropoietic
system, proliferative-response deficits were
assessed by comparing proliferative para-
meters in stressed and non-stressed pre-
treated mice to those in age-matched controls.
In kidney studies, integrated cell production
during the course of the FA response was
estimated by determining the area under the
post-stress time-course curves. The relative
cell production in drug-pretreated mice was
expressed as a percentage of control. The
t test was used when appropriate to assess
significant differences. P<0 05 was taken as
rejecting the null hypothesis.
RESULTS
Renal tubule regeneration
By 24 h after FA, the kidneys were
pale yellow with focal haemorrhages.
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Histologically, the tubular epithelium
was swollen, with cytoplasmic vacuolation
as well as nuclear fragmentation. Brightly
staining eosinophilic material andsloughed
cells were seen in the lumen ofthe tubules.
The glomeruli appeared to be unaffected.
The tubular lesions are probably a mani-
festation of local changes in electrolyte
balance induced by the precipitation of
FA at neutral or acid pH (Threlfall et al.,
1966; Byrnes et al., 1972b). The findings
are not inconsistent with nephrotoxic
acute renal failure and tubular necrosis
(Baserga et al., 1968; Byrne et al., 1972a,
b). Kidney weights (as percentage of body
wt + s.e.) in DMN-pretreated mice (0.731 +
0-017%) before FA stress were similar to
control (0.733 + 0-0210%). Kidney weights
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FIG. 1.-Tlie dose-dependence of [3H]dT
ulptake in the kidney 48 h after FA stress.
FA was administered in saline (closed
symbols) or in 0-3N Na2CO3 (open symbols)
to untreated control mice (*, 0) and
mice pretreated with DMN (*), (ADR (*)
or DDP (-). Each symbol denotes mean
+ s.e. for 4-5 kidneys.
before FA in ADR (0-562 + 0 020%) and
DDP- (0.573 +0o049%o) pretreated mice
were, however, subnormal.
Fig. 1 shows the FA dose response for
[3H]dT uptake by the kidney 48 h after
FA given in saline (50-125 mg/kg) or in
0-3M Na2CO3 (100-250 mg/kg). With both
vehicles a linear dose response was found.
Increased [3H]dT uptake was seen with
as little as 50 mg/kg FA. When FA was
administered in saline, [3H]dT uptake was
stimulated more than for a similar dose
in 0-3M Na2CO3. Toxic deaths were noted
at doses above 125 mg/kg FA in saline.
No deaths were noted at 200 mg/kg in
Na2CO3, but 25% mortality was seen at
the 250mg/kg level.
Pretreatment with 8 mg/kg DDP or
10 mg/kg ADR 120 days before FA stress
depressed the [3H]dT uptake at 48 h.
Pretreatment with 1-3 mg/kg DMN, how-
ever, did not significantly compromise the
48h regenerative response.
The time course for renal [3H]dT uptake
after 125 mg/kg FA (saline) is shown in
5.0-
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FIG. 2.-[3H]dT uptake in kidneys from con-
trol mice (0) and mice pretreated with
DAIN (*), ADR (*) or DDP (A) as a
function of time after 125 mg/kg FA in
saline. Each symbol denotes the mean
+s.e. for 4-5 kidneys.
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FiG. 3.-Changes in LI with time after
125 mg/kg FA in saline in mice pretreated
with DMN (*), ADR (*) or DDP (-)
and controls (@*). Each symbol denotes the
mean + s.e. for 4-5 kidneys.
Fig. 2. In these studies FA stress was
imposed 120 days after drug treatment.
[3H]dT uptake in control kidneys was
increased by 12 h, but maximal incorpora-
tion was not noted until 48 h. Although
the initial increase in [3H]dT uptake in all
pretreated groups was delayed, the overall
response in DMN-treated mice was similar
to control. On the other hand, the response
in DDP and ADR-treated mice was sub-
stantially subnormal throughout the per-
iod studied. It was not possible to obtain
96h points for the 10mg/kg ADR group,
due to acute mortality 72-96 h after FA.
No mortality was seen in the other treated
groups.
Fig. 3 shows the changes in the LI of
cortical tubular epithelium after FA
(125mg/kgin saline).LIsweresignificantly
increased 12 h after FA in control kid-
neys. Maximal LI, noted 36 h after treat-
ment, was increased about 140-fold. In
mice pretreated with DDP or ADR, the
response was delayed and subnormal for
72 h. The response in DMN-treated mice
closely paralleled that in the controls.
If all tubular epithelial cells that take
up [3H]dT subsequently divide, the area
under the d/min/kidney and LI time-
course curves would be proportional to
the total cell production during the experi-
ment. The relative proliferative responses
of the renal epithelium in drug-pretreated
mice are shown in Table I. Although the
magnitude of the LI response was greater
than that for d/min/kidney, the relative
integral deficits in cell production for these
two response parameters were similar.
Whilst 1-3 mg/kg DMN produced only a
25% deficient response at 120 days, the
deficits in ADR- (70.4%) and DDP
(54.3%) -treated mice were more severe.
The deficiency in response could also be
estimated from the ratio ofthe LI response
in pretreated mice at 36 h to that in con-
trols. These data indicate that, although
DMN induced only a modest long-term
TABLE I.-Relative proliferative response to FA in mice pretreated with DMN, ADR
and DDP
Relative response
(% ofcontrol)
70-6
32.2
43.4
100-0
LIb
72 -6
29-7
38-6
100-0
Integrated cell production (%)
(AVC pretreated/AVC control
d/min/kidney RRIc
77-5 24 8
29-5 70-4
52-8 54.3
100-0 0-0
a Max LI was seen at 36 h for DMN, DDP and control mice and at 72 h for ADR.
Prestress LIs are those for drug-treated but not FA-stressed.
b Ratio of area under response curves (AVC) (d/min/kidney, Fig. 3; LI, Fig. 4) for
pretreated and control expressed as a percentage.
c Combined response deficit for LI and d/min/kidney responses.
Renal residual injury (RRI) =[1-(AVC Pretreated/AVC Control)] x 100%
Max LIa
DMN
ADR
DDP
Control
Prestress LI
101
46
62
143
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TABLE II.-Erythropoietic response to anaemia stress in spleens and marrows 120 days
Drug treatmeint
DDP (8 mg/kg)
Bled
ion-bled
°0 clhange
D)AN (1 3 mg/kg)
Bled
non-bled
°0 clhange
ADR (10 mg/kg)
Bled
non-bled
0/ cliange
Control
Bledc
non-bledI
%0 change
after drug treatment
,spi. WNtsa Spl. NRBCb Marrwo NRBC
0.284+0.103c 4-1+0-8 28-0+ 1-7
0-2377+-0-014 4-5+0-4 22-6+1-1
+ 19 NS + 24
(P253+0 027 5-1+0 6 20'8+1 3
0-210+0-018 2'0+0-3 22-5+0-9
+ 20 + 155 NS
(0-288++0009
0-237+0-012
+22
0-469+ 0*020
0-311 + 0-011
+51
1-4+0-2 19-2+0-7
1-8 0-29 16-7--->0-4
NS +15
23-4+ 2-4
37 + 0- 7
+532
41 -0+1-5
18-6+0-7
+ 121
(I Spleen wvet weiglits as a % of total body wt.
1) Nucleated erythrocyte precursors as a 00 of total cells.
c MIean + s.e. for 8 mice/group.
renal injury, ADR and DDP caused signi-
ficant long-term reduction in the renal
proliferative reserve.
Erythropoiesis
Anaemic stress induced by bleeding was
used to evaluate the ability of the spleen
and femoral marrow to mount a regenera-
tive response to an acute proliferative
demand 120 days after drug treatment.
Table II shows spleen weights and
erythrocyte-precursor fractions in femoral
marrows and spleen before and 48 h after
bleeding. Control spleen weights increased
- 5000 after bleeding, whereas, spleen
weights in pretreated mice increased only
by 20%. The nucleated erythrocyte-
precursor fractions in spleens and femoral
marrows from control mice increased by
500%o and 100% respectively. In pre-
treated mice, although significant ery-
throid responses were noted in the spleen
(DMN) and femoral marrows (DDP,
ADR), all responses were significantly
subnormal.
DISCUSSION
Clinically observed delayed toxicities
appear to be a consequence of drug- or
radiation-induced reductions in the ability
of the cell renewal system to provide
differentiated cells. This could be a result
of reduced stem-cell numbers (multi-
plicity), subnormal stem-cell proliferation
(proliferative reserve) or both. Although
acute toxicities are the major clinical
concern in the design of therapeutic
strategies, delayed proliferation defects
resulting from aggressive treatments
could increase the acute toxicities after
subsequent treatments. A better under-
standing ofthe limitations and sensitivities
of normal cell-renewal systems may pro-
vide some insight into ways in which
persistent long-term injury can be
minimized.
In experimental animal models we and
others have used acute anaemia induced
by bleeding as an erythropoietic stress
(Braunschweiger et al., 1980a, b; Gong
et al., 1969), acute abdominal radiation as
an acute GI stress (Schenken et al., 1979),
serial marrow transplantation as a specific
proliferative stress for the CFUs (Botnick
et al., 1978), and unilateral nephrectomy
(Donaldson et al., 1978 and unpublished;
Moskowitz et al., 1980; Resnick et al.,
1972) as a specific proliferative stimuli
to detect and quantitate long-lasting
proliferative defects before they become
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manifest as life-threatening toxicities. In
the kidney, high-dose FA has been used
to study the morphological (Byrne et al.,
1972b) and biochemical (Baserga et al.,
1968; Byrnes et al., 1972a; Taylor et al.,
1966; Threlfall et al., 1966, 1967) events
leading to initiation of DNA synthesis
after acute renal failure. In the present
studies, the time course and magnitude of
th9 proliferative response to FA-induced
tubular necrosis in the controls was
similar to that observed by Baserga et al.
(1968).
un comparison with the respective con-
trol values, both d/min/kidney and LI
endpoints gave similar estimates of the
response deficits in DDP- and ADR-
pretreated mice. In rats, Taylor et al.
(1976) observed subnormal FA responses
up to 10 days after 4 mg/kg DDP. The
response at longer intervals was not, how-
ever studied. More recently Kovacs et al.
(1981) showed that proliferative homoeo-
stasis in mouse kidney is not re-established
until about 45 days after 8 mg/kg DDP.
The proliferative response to FA at this
time was also subnormal. In these studies
the response deficit was about 75% at
45 days. In the present study the response
deficit was about 55% 120 days after
DDP, suggesting that the proliferative
defect repaired slowly, with a recovery
half-time of at least 120 days.
Clinically DDP has been clearly shown
to induce long-lasting renal injury (Ansair
et al., 1980; Bruno et al., 1980; Dentino
et al., 1978; Freeman et al., 1979) which
may in part be due to the rather slow
clearance (Handelsman et al., 1974;
Litterst et al., 1979). Although renal
toxicity from ADR has not been identified
as a significant clinical problem in adults,
children treated for Wilms' tumourdemon-
strated subnormal compensatory renal
growth after chemotherapy or radiation-
chemotherapy combinations (Arneil et al.,
1974). In animal models, anthracycline
drugs have been shown to be nephrotoxic
(Moskowitz et al., 1980; Sternberg, 1970).
In young mice, ADR treatment after
unilateral nephrectomy induced a long-
lasting delay in compensatory renal re-
growth which was most probably related
to a delay in unilateral-nephrectomy-
induced mitosis. A similar effect has been
found in compensating kidneys after
mithramycin (Resnick et al., 1972), radia-
tion (Donaldson et al., 1978) and com-
bined-modality therapy (Donaldson et al.,
unpublished). Although renal-function
tests were not done in the present studies,
drug-induced inhibition of compensatory
renal regrowth after nephrectomy has
been shown to be associated with late
morphological and functional abnormali-
ties (Donaldson et al., unpublished).
In marrows and spleens 1-3 mg/kg DMN
produced a similar level of erythropoietic
injury to 10 mg/kg ADR, even though
DMN produced little long-lasting renal
injury. Previous studies have indicated
that both agents are rapidly cleared from
the plasma, highly concentrated in the
kidney, and slowly cleared and excreted
in the urine (Schwartz & Grindey, 1979;
Siemann & Sutherland, 1979; Yesair et al.,
1972). DMN is, however, concentrated
more in the haemopoietic tissues than is
ADR (Schwartz & Grindey, 1979). Fur-
ther, DMN has been shown to be 2-3
times more toxic than ADR for haemo-
poietic stem cells (Razek et al., 1972).
From the standpoint of renal injury,
DMN is more rapidly metabolized than
ADR, and the initial renal clearance may
also be more rapid. Thus, concentration
time for DMN in kidney could be sub-
stantially less than for ADR (Yesair,
etal., 1972).
We have previously shown that both
ADR (Braunschweiger et al., 1980b) and
DDP (Braunschweiger et al., 1980a) can
induce long-lasting dose-dependent pro-
liferative defects in the haemopoietic sys-
tem of Ha/ICR mice. The results in the
present studies, using BDF1 mice, are
not inconsistent withourprevious findings.
Furthermore, Lohrmann et al. (1978)
demonstrated a long-lasting residual
haemopoietic defect in patients receiving
adjuvant chemotherapy with cyclophos-
phamide and ADR. In these studies sub-
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normal circulating CFU-C levels were
found up to 3 years after treatment.
The underlying mechanism of the drug-
induced reduction in proliferative reserve
is unclear. This defect might be a mani-
festation ofimproperly repaired molecular
injury, persistent intracellular drug reten-
tion, or perhaps irreparable injury to
stroma or other tissues performing sup-
port functions during induced prolifera-
tion. Studies addressed to these and other
questions regarding time-dose modifica-
tions of these proliferative defects are
continuing.
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